Published in Cancer Weekly, September 23rd, 2003
"The frequency of these germline variants was examined in a population-based, incident series of 62 ocular melanoma cases and ethnicity-matched population controls," wrote C. Vajdic and colleagues, Queensland Institute of Medical Research, Cancer & Cell Biology Division.
"In both cases and controls, 59% of individuals carried at least one MC1R variant and there were no significant differences in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.